Showing results (191-200 of 322) with videos related to

Sort By:
Pageof 33
Leukemia & Lymphoma|February 25, 2015
A phase 2 study of inotuzumab ozogamicin and rituximab, followed by autologous stem cell transplant in patients with relapsed/refractory diffuse large B-cell lymphomaNina D Wagner-Johnston, Andrè Goy, Maria A Rodriguez, et al.
Leukemia & Lymphoma|April 16, 2020
The clinical outcomes of rituximab biosimilar CT-P10 (Truxima®) with CHOP as first-line treatment for patients with diffuse large B-cell lymphoma: real-world experienceKyoungmin Lee, Joo Young Ha, Ah Ra Jung, et al.
British Journal of Haematology|June 9, 2009
Natural polyphenols antagonize the antimyeloma activity of proteasome inhibitor bortezomib by direct chemical interactionTae Young Kim, Jongmin Park, Bora Oh, et al.
Leukemia & Lymphoma|October 27, 2021
Prognostic significance of serum β2-microglobulin levels in patients with peripheral T-cell lymphoma not otherwise specifiedHyung-Don Kim, Hyungwoo Cho, Byeong Seok Sohn, et al.
Transfusion|December 9, 2004
Initiation of peripheral blood progenitor cell harvest based on peripheral blood hematopoietic progenitor cell counts enumerated by the Sysmex SE9000Cheolwon Suh, Shin Kim, Sang-Hee Kim, et al.
Investigational New Drugs|March 10, 2018
Phase I study of CKD-581, a pan-histone deacetylase inhibitor, in patients with lymphoma or multiple myeloma refractory to standard therapyHyungwoo Cho, Dok Hyun Yoon, Kyu-Pyo Kim, et al.
Leukemia & Lymphoma|June 27, 2009
Clinical features and treatment outcomes of adult B- and T-lymphoblastic lymphoma: results of multicentre analysis in KoreaMyung Hee Chang, Seok Jin Kim, Kihyun Kim, et al.
Investigational New Drugs|June 24, 2009
Yttrium-90-ibritumomab tiuxetan in combination with intravenous busulfan, cyclophosphamide, and etoposide followed by autologous stem cell transplantation in patients with relapsed or refractory B-cell non-Hodgkin's lymphomaByung Woog Kang, Won Seog Kim, Chul Kim, et al.
Cancer Research and Treatment|December 19, 2015
Growth Suppression and Induction of Chemosensitivity in Human Gallbladder Epithelial Carcinoma Cells (GBCE) by Adenovirus-Mediated Transfer of the Wild-type p53 GeneSung Bae Kim, Myung Hwan Kim, Sung Koo Lee, et al.
Cancers|August 13, 2020
First-Line Treatment for Primary Breast Diffuse Large B-Cell Lymphoma Using Immunochemotherapy and Central Nervous System Prophylaxis: A Multicenter Phase 2 TrialHo-Young Yhim, Dok Hyun Yoon, Seok Jin Kim, et al.
Pageof 33